Great West Life Assurance Co. Can Acquires New Position in HealthEquity, Inc. (NASDAQ:HQY)

Great West Life Assurance Co. Can purchased a new stake in HealthEquity, Inc. (NASDAQ:HQYGet Rating) in the 3rd quarter, HoldingsChannel.com reports. The firm purchased 56,014 shares of the company’s stock, valued at approximately $3,762,000.

Other large investors have also modified their holdings of the company. SG Americas Securities LLC raised its holdings in shares of HealthEquity by 42.4% in the 2nd quarter. SG Americas Securities LLC now owns 23,003 shares of the company’s stock valued at $1,412,000 after purchasing an additional 6,849 shares in the last quarter. AlphaCrest Capital Management LLC raised its holdings in shares of HealthEquity by 26.7% in the 2nd quarter. AlphaCrest Capital Management LLC now owns 4,390 shares of the company’s stock valued at $270,000 after purchasing an additional 926 shares in the last quarter. Ensign Peak Advisors Inc raised its holdings in shares of HealthEquity by 0.3% in the 2nd quarter. Ensign Peak Advisors Inc now owns 360,498 shares of the company’s stock valued at $22,131,000 after purchasing an additional 908 shares in the last quarter. Comerica Bank raised its holdings in shares of HealthEquity by 0.9% in the 2nd quarter. Comerica Bank now owns 38,917 shares of the company’s stock valued at $2,331,000 after purchasing an additional 337 shares in the last quarter. Finally, Texas Permanent School Fund raised its holdings in shares of HealthEquity by 2.9% in the 2nd quarter. Texas Permanent School Fund now owns 60,977 shares of the company’s stock valued at $3,743,000 after purchasing an additional 1,708 shares in the last quarter. Institutional investors own 99.54% of the company’s stock.

Analyst Upgrades and Downgrades

HQY has been the subject of several recent research reports. Raymond James boosted their price target on shares of HealthEquity from $75.00 to $85.00 and gave the company an “outperform” rating in a report on Monday, December 12th. Robert W. Baird lifted their price objective on shares of HealthEquity to $75.00 in a research report on Monday, December 12th. Guggenheim lifted their price objective on shares of HealthEquity from $89.00 to $94.00 and gave the stock a “buy” rating in a research report on Wednesday, December 7th. StockNews.com downgraded shares of HealthEquity from a “hold” rating to a “sell” rating in a research report on Friday, January 6th. Finally, Royal Bank of Canada lifted their price objective on shares of HealthEquity from $70.00 to $75.00 in a research report on Monday, December 5th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and eight have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $81.23.

HealthEquity Stock Down 1.3 %

NASDAQ:HQY opened at $56.64 on Tuesday. The company has a market cap of $4.79 billion, a PE ratio of -80.91, a P/E/G ratio of 2.95 and a beta of 0.80. HealthEquity, Inc. has a twelve month low of $48.42 and a twelve month high of $79.20. The company has a current ratio of 3.01, a quick ratio of 3.01 and a debt-to-equity ratio of 0.48. The company’s 50 day moving average is $61.37 and its two-hundred day moving average is $64.63.

HealthEquity (NASDAQ:HQYGet Rating) last released its earnings results on Tuesday, December 6th. The company reported $0.21 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.01. The company had revenue of $216.09 million for the quarter, compared to the consensus estimate of $206.58 million. HealthEquity had a negative net margin of 7.07% and a positive return on equity of 2.82%. Analysts anticipate that HealthEquity, Inc. will post 0.74 EPS for the current year.

Insiders Place Their Bets

In other HealthEquity news, Director Gayle Furgurson Wellborn sold 5,237 shares of the business’s stock in a transaction that occurred on Wednesday, December 14th. The shares were sold at an average price of $62.00, for a total transaction of $324,694.00. Following the sale, the director now owns 12,023 shares of the company’s stock, valued at approximately $745,426. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 2.80% of the stock is owned by insiders.

HealthEquity Company Profile

(Get Rating)

HealthEquity, Inc provides range of solutions for managing health care accounts. The firm’s offers its solutions for employers, health plans, brokers, consultants and financial advisors. Its services include HAS, FSA, HRA, DCRA, 401(k), Commuter, COBRA and HIA. It also offers products like healthcare saving and spending platform, health savings accounts, investment advisory services, reimbursement arrangements, and healthcare incentives.

See Also

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQYGet Rating).

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.